Northside Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.53M Sell
35,283
-670
-2% -$78.4K 0.37% 62
2026
Q1
$4.32M Sell
35,953
-750
-2% -$86.6K 0.38% 61
2025
Q4
$3.86M Sell
36,703
-100
-0.3% -$9.39K 0.34% 61
2025
Q3
$3.09M Sell
36,803
-1
-0% -$82 0.28% 65
2025
Q2
$2.91M Buy
36,804
+34,334
+1,390% +$2.73M 0.22% 64
2025
Q1
$222K Sell
2,470
-300
-11% -$28K 0.04% 108
2024
Q4
$276K Buy
2,770
+300
+12% +$30.9K 0.07% 94
2024
Q3
$280K Sell
2,470
-200
-7% -$23.8K 0.04% 89
2024
Q2
$331K Hold
2,670
0.06% 77
2024
Q1
$352K Hold
2,670
0.06% 74
2023
Q4
$291K Buy
2,670
+1
+0% +$104 0.09% 86
2023
Q3
$275K Sell
2,669
-1
-0% -$108 0.06% 79
2023
Q2
$308K Hold
2,670
0.11% 71
2023
Q1
$284K Buy
2,670
+129
+5% +$13.9K 0.08% 73
2022
Q4
$282K Sell
2,541
-1,532
-38% -$157K 0.08% 71
2022
Q3
$351K Hold
4,073
0.11% 61
2022
Q2
$371K Hold
4,073
0.12% 58
2022
Q1
$334K Hold
4,073
0.09% 65
2021
Q4
$312K Hold
4,073
0.08% 65
2021
Q3
$306K Hold
4,073
0.08% 68
2021
Q2
$317K Sell
4,073
-285
-7% -$21.2K 0.08% 69
2021
Q1
$321K Buy
4,358
+74
+2% +$5.46K 0.09% 64
2020
Q4
$334K Sell
4,284
-81
-2% -$6.2K 0.1% 63
2020
Q3
$345K Sell
4,365
-1,229
-22% -$96.3K 0.11% 64
2020
Q2
$413K Buy
+5,594
New +$421K 0.14% 66
2019
Q4
Sell
-4,897
Closed -$393K 97
2019
Q3
$393K Buy
+4,897
New +$392K 0.14% 66
2017
Q2
Sell
-6,186
Closed -$375K 100
2017
Q1
$375K Buy
+6,186
New +$375K 0.1% 100

Other funds holding MRK

Northside Capital Management's MRK Position: Q2 2026 in Review

Northside Capital Management reduced its Merck (MRK) stake by 1.9% in Q2 2026, selling an estimated $78.4K and leaving 35,283 shares worth $4.53M. The position accounts for 0.37% of the portfolio, ranked #62.

Northside Capital Management first reported a position in MRK in Q1 2017 and has held it in 27 quarters since. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Northside Capital Management held 35,283 shares of Merck worth $4.53M as of Q2 2026.
  • Northside Capital Management sold 670 Merck shares in Q2 2026, an estimated $78.4K.
  • Merck made up 0.37% of Northside Capital Management's portfolio in Q2 2026, its #62 holding.
  • Northside Capital Management first reported a position in Merck in Q1 2017 and has held it in 27 quarters since.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Northside Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.